SPECTRUM PHARMACEUTICALS INC Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value
SPECTRUM PHARMACEUTICALS INC had Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value of $139.00 thousand as of 2023-03-31, per its 10-Q filed 2023-05-11.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 · last filed 2023-05-11
- 2023-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $139.00K.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2022-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
- 2021-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value $0.00.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value |
|---|---|
| 2023-03-31 | $139.00K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $0.00 10-K · filed 2023-03-31 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 |
| 2021-12-31 | $0.00 10-K · filed 2022-03-18 |
| 2020-12-31 | $503.00K 10-K · filed 2021-03-31 |
| 2019-12-31 | $1.00K 10-K · filed 2020-03-02 |
| 2018-12-31 | $8.42M 10-K · filed 2019-02-28 |
| 2017-12-31 | $138.80M 10-K · filed 2018-03-07 |
| 2016-12-31 | $2.83M 10-K · filed 2017-03-14 |
| 2015-12-31 | $7.16M 10-K · filed 2016-03-14 |
| 2014-12-31 | $11.68M 10-K · filed 2015-03-13 |
| 2013-12-31 | $24.08M 10-K · filed 2014-03-12 |
| 2012-12-31 | $39.41M 10-K/A · filed 2013-12-06 |